You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

newly diagnosed Glioblastoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme Trial (WP1066)

Not yet recruiting
  • Glioblastoma Multiforme
  • (no location specified)
May 18, 2023

Glioblastoma, IDH-wildtype Trial in Beijing (Elemene, Placebo)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • Beijing, China
    Peking Union Medical College Hospital
Apr 22, 2023

Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

Recruiting
  • Glioblastoma, IDH-wildtype
  • +4 more
  • Eflornithine (Dose Level 1)
  • +3 more
  • Cleveland, Ohio
    The Cleveland Clinic
May 19, 2023

Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

Active, not recruiting
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 30, 2023

Newly Diagnosed Glioblastoma Trial (combinations of up to 3 FDA approved drugs from a panel of compounds)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • combinations of up to 3 FDA approved drugs from a panel of compounds
  • (no location specified)
Jan 19, 2023

Glioblastoma Trial (Ipilimumab)

Recruiting
  • Glioblastoma
  • Aberdeen, United Kingdom
  • +3 more
Jan 12, 2023

Glioblastoma Trial in Boston (ITI-1001)

Not yet recruiting
  • Glioblastoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 13, 2023

Glioblastoma, Newly Diagnosed Glioblastoma Trial in Stanford (device, drug, radiation)

Recruiting
  • Glioblastoma
  • Newly Diagnosed Glioblastoma
  • Optune
  • +3 more
  • Stanford, California
    Stanford University
Aug 1, 2022

Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • (no location specified)
Feb 13, 2023

Glioblastoma Trial run by the NCI (drug, biological, other)

Completed
  • Glioblastoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 23, 2022

Glioblastoma Multiforme of Brain Trial in Gatineau (avelumab)

Completed
  • Glioblastoma Multiforme of Brain
  • avelumab
  • Gatineau, Quebec, Canada
    Clinique Neuro-Outaouais
Jul 19, 2022

Newly Diagnosed Glioblastoma Patients

Recruiting
  • Glioblastoma
  • stressors
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Aug 24, 2022

Malignant Tumor, Malignant Tumor of Brain Trial in Taiwan (NBM-BMX Capsule, Temozolomide, Standard radiotherapy)

Recruiting
  • Malignant Neoplasm
  • Malignant Neoplasm of Brain
  • NBM-BMX Capsule
  • +2 more
  • Hualien City, Taiwan
  • +4 more
Aug 22, 2023

Glioblastoma Trial in Barcelona, Madrid (Azeliragon 5 mg, Azeliragon 10 mg, Azeliragon 20 mg)

Not yet recruiting
  • Glioblastoma
  • Azeliragon 5 mg
  • +2 more
  • Barcelona, Spain
  • +3 more
Dec 2, 2022

Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV) Trial in Baltimore (Chemotherapy with Temodar.,

Terminated
Has Results
  • Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)
  • Chemotherapy with Temodar.
  • Radiation therapy
  • Baltimore, Maryland
    Ummc Msgcc
Dec 1, 2022

Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)

Recruiting
  • Glioblastoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Using Genomic, Histologic and Radiomic Analysis to Evaluate

Suspended
  • Glioblastoma
  • Tumor Biopsy
  • Ann Arbor, Michigan
    University of Michigan
Oct 6, 2022

Neoplastic Disease, Glioblastoma, Glioblastoma Multiforme Trial (131I-IPA)

Not yet recruiting
  • Neoplastic Disease
  • +2 more
  • (no location specified)
Jul 6, 2022

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Astrocytoma, Grade III Trial in San Antonio, Zuerich (Debio 0123,

Not yet recruiting
  • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
  • Astrocytoma, Grade III
  • Debio 0123
  • +2 more
  • San Antonio, Texas
  • +1 more
Mar 9, 2023

Glioblastoma Trial (Gabapentin, Sulfasalazine, Memantine)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Dec 15, 2022

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 16, 2022

High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma Trial in Fullerton, Newport Beach, Santa Monica (ABI-009,

Active, not recruiting
  • High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
  • Fullerton, California
  • +2 more
Jun 13, 2022

Glioblastoma Trial in Oklahoma City (OKN 007, Temozolomide, Photon/Proton IMRT)

Recruiting
  • Glioblastoma
  • OKN 007
  • +2 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center, University of Oklahoma Health Sciences
Jun 17, 2022

Glioblastoma Trial in Birmingham (Autologous genetically modified gamma-delta T cells, Allogeneic genetically modified

Not yet recruiting
  • Glioblastoma
  • Autologous genetically modified gamma-delta T cells
  • Allogeneic genetically modified gamma-delta T cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 16, 2022

Newly-diagnosed Glioblastoma Trial in Beijing (CAN008, Placebo)

Recruiting
  • Newly-diagnosed Glioblastoma
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Jul 10, 2022